MSFBX
Price
$33.93
Change
-$0.00 (-0.00%)
Updated
May 9 closing price
Net Assets
2.66B
RWIBX
Price
$64.07
Change
+$0.11 (+0.17%)
Updated
May 9 closing price
Net Assets
124.77B
Ad is loading...

MSFBX vs RWIBX

Header iconMSFBX vs RWIBX Comparison
Open Charts MSFBX vs RWIBXBanner chart's image
Morgan Stanley Inst Global Franchise A
Price$33.93
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets2.66B
American Funds Capital World Gr&Inc R2
Price$64.07
Change+$0.11 (+0.17%)
VolumeN/A
Net Assets124.77B
MSFBX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSFBX vs. RWIBX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSFBX is a Buy and RWIBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 125B vs. MSFBX (2.66B). RWIBX pays higher dividends than MSFBX: RWIBX (0.91) vs MSFBX (0.43). MSFBX was incepted earlier than RWIBX: MSFBX (23 years) vs RWIBX (23 years). RWIBX (1.51) is less costly to investors than MSFBX (1.17). MSFBX is a more actively managed with annual turnover of: 35.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than MSFBX: RWIBX (250) vs MSFBX (1000). RWIBX annual gain was more profitable for investors over the last year : 1.36 vs. MSFBX (-0.56). RWIBX return over 5 years is better than : 47.10 vs. MSFBX (31.68).
MSFBXRWIBXMSFBX / RWIBX
Total Expense Ratio1.171.5177%
Annual Report Gross Expense Ratio1.171.5177%
Fund Existence23 years23 years-
Gain YTD4.1442.552162%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.66B125B2%
Annual Yield % from dividends0.430.9148%
Returns for 1 year-0.561.36-41%
Returns for 3 years15.5728.1255%
Returns for 5 years31.6847.1067%
Returns for 10 years66.1537.93174%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVXLX57.58N/A
N/A
Smead International Value Inv
MUEAX34.15N/A
N/A
MFS Blended Research Core Equity A
BGRUX89.76N/A
N/A
Baron Growth R6
BALSX9.29N/A
N/A
BlackRock U.S. Insights Lon/Shr Eq Inv A
MGOCX34.43-0.11
-0.32%
NYLI WMC Enduring Capital Class C